Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.5 EUR | 0.00% | +5.71% | +1.65% |
Jun. 03 | EEX's Nasdaq deal risks probe as remedies seen as insufficient, sources say | RE |
Jun. 03 | EU regulators unlikely to seek feedback on EEX remedies on Nasdaq deal, sources say | RE |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company is in debt and has limited leeway for investment
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.65% | 37.97B | - | ||
+4.84% | 77.35B | B+ | ||
+1.76% | 64.03B | B+ | ||
+1.04% | 44.2B | B+ | ||
+1.57% | 34.17B | B+ | ||
-25.02% | 11.54B | A- | ||
+19.64% | 10.51B | B+ | ||
-1.63% | 7.73B | B+ | ||
+16.57% | 7.66B | B- | ||
-1.37% | 5.64B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DB1 Stock
- 63DA Stock
- Ratings Deutsche Börse AG